Y-Mabs Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Y-Mabs Therapeutics Inc
TickerYMAB
CIK #0001722964
CUSIP984241109
SectorLife Sciences - Pharmaceutical Preparations
Address750 Third Avenue 9th Floor, New York, NY 10017
Source [EDGAR]
CIK Filing 2011 - 2024
[0001722964] 10-K
[0001722964] 10-Q
[0001722964] 3
[0001722964] 4
[0001722964] 8-K
[0001722964] SC 13D
[0001722964] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Acorn BioVentures LP Y-Mabs Therapeutics Inc [2023-04-03] 2.2
WG Biotech APS Y-Mabs Therapeutics Inc [2023-02-14] 0.6
Vanguard Group Inc Y-Mabs Therapeutics Inc [2023-02-09] 5.17
BlackRock Inc Y-Mabs Therapeutics Inc [2021-02-02] 6.0
Cheung Nai-Kong V Y-Mabs Therapeutics Inc [2020-08-26] 8.64
BlackRock Inc Y-Mabs Therapeutics Inc [2020-02-07] 5.1
Wellington Management Group LLP Y-Mabs Therapeutics Inc [2020-01-28] 6.18
Memorial Sloan-Kettering Cancer Center Y-Mabs Therapeutics Inc [2018-11-07] 8.04
Sofinnova Venture Partners X LP Y-Mabs Therapeutics Inc [2018-10-02] 11.0
HBM Healthcare Investments Cayman Ltd Y-Mabs Therapeutics Inc [2018-10-01] 9.0
Form 3/4/5 Filer 2011 - 2024
Gill David N
Y-mAbs Therapeutics, Inc.
Healy James
Tyagi ASHU
Ber Gerard
Wedell-Wedellsborg Johan
Hamill Laura
WG Biotech ApS
Smith Susan Laura
Lisby Steen
Lund-Hansen Torben
Rajah Vignesh
Wilms Joris
Kruse Bo
Gad Thomas
Moller-San Pedro Claus Juan
Herman Philip Karl
Ahmed Mahiuddin
Raskin Gregory S
Buschle Michael
Form 13F Holdings
Firm Period DFND Voting Shares
BlackRock Inc. [2023-03-31] SOLE 2,341,741.0 2,361,093.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,212,113.0
Sofinnova Investments Inc [2023-03-31] SOLE 2,194,278.0 2,194,278.0
Polar Capital Holdings Plc [2023-03-31] DFND 1,991,929.0 1,991,929.0
D. E. Shaw & Co., Inc. [2023-03-31] DFND 790,756.0 790,956.0
State Street Corp [2023-03-31] DFND 723,830.0 762,830.0
Geode Capital Management LLC [2023-03-31] DFND 662,645.0 662,645.0
Millennium Management LLC [2023-03-31] SOLE 623,091.0 623,091.0
AQR Capital Management LLC [2023-03-31] DFND 375,256.0 479,293.0
Acadian Asset Management LLC [2023-03-31] DFND 399,582.0 399,582.0
Point72 Asset Management LP [2023-03-31] DFND 0.0 357,218.0
Nuveen Asset Management LLC [2023-03-31] DFND 333,392.0 333,392.0
AIGH Capital Management LLC [2023-03-31] SOLE 323,925.0 323,925.0
Jacobs Levy Equity Management Inc [2023-03-31] SOLE 323,897.0 323,897.0
Citadel Advisors LLC [2023-03-31] DFND 314,810.0 314,810.0
Northern Trust Corp [2023-03-31] DFND 7,170.0 302,329.0
Morgan Stanley [2023-03-31] DFND 244,743.0 250,449.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 235,640.0 235,640.0
Two Sigma Advisers LP [2023-03-31] SOLE 182,700.0 209,200.0
JPMorgan Chase & Co [2023-03-31] DFND 165,766.0 195,435.0
Memorial Sloan Kettering Cancer Center [2023-03-31] SOLE 191,176.0 191,176.0
Goldman Sachs Group Inc [2023-03-31] DFND 190,771.0 190,791.0
Connor Clark & Lunn Investment Management Ltd [2023-03-31] SOLE 174,114.0 174,114.0
XTX Topco Ltd [2023-03-31] DFND 163,277.0 163,277.0
GSA Capital Partners LLP [2023-03-31] SOLE 161,509.0 161,509.0
AllianceBernstein LP [2023-03-31] DFND 155,639.0 155,639.0
Two Sigma Investments LP [2023-03-31] SOLE 155,627.0 155,627.0
State of Wisconsin Investment Board [2023-03-31] SOLE 150,800.0 150,800.0
STRS Ohio [2023-03-31] SOLE 148,800.0 148,800.0
New York Life Investment Management LLC [2023-03-31] SOLE 145,808.0 145,808.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com